中國恆泰(02011.HK)斥逾670萬人幣向關連方購買染色機等設備
中國恆泰集團(02011.HK)公布,公司間接非全資附屬開易廣東荊門分公司作為買方,與開易荊門訂立設備購買協議,開易廣東荊門同意向對方購買設備,以提高產能、整體生產交貨期及產品質量,從而滿足客戶需求,代價為671.76萬元人民幣。
設備包括但不限於染色機、繞線機、自動化蒸爐、Datacolor 800臥式分光光度計、Datacolor AUTOLAB TF實驗室配料機以及水軟化器。
開易荊門分別由許錫鵬及許錫南間接擁有50%及50%權益。許錫鵬及許錫南透過Keen New於KEE International BVI擁有15%股權;及許錫鵬及許錫南分別為公司若干附屬公司之董事,故擬進行之交易構成公司關連交易。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.